We are actively recruiting for future posts in 2027. Please note if you are successful through the process, you are will be placed on one of our 2027 intakes. Serving an estimated population of nearly 600,000
Scientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs